Context: The clinical utility and implications of continuous glucose monitoring (CGM) in cystic fibrosis (CF) are unclear. Objective: We examined the correlation between CGM measures and clinical ou
BackgroundDiabetic nephropathy (DN) is a complication of systemic microvascular disease in diabetes mellitus. Abnormal glycolysis has emerged as a potential factor for chronic renal dysfunction in DN.
The Asia Pacific Diabetic Assays report features an extensive regional analysis, identifying market penetration levels across major geographic areas. It highlights regional growth trends and opportuni
Baseline Parameters according to HbA1c dichotomized at the cut-off indicative of diabetes or prediabetes according to the American Diabetes Association [27].
